LACTULOSE- lactulose solution United States - English - NLM (National Library of Medicine)

lactulose- lactulose solution

par pharmaceutical - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE SOLUTION- lactulose solution usp, 10 g/15 ml solution United States - English - NLM (National Library of Medicine)

lactulose solution- lactulose solution usp, 10 g/15 ml solution

bajaj medical, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia level by 25 to 50%; this is generally paralleled by an improvement in the patients’ mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients’ protein tolerance is also frequently observed with lactulose solution therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose solution has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE SOLUTION- lactulose solution usp, 10 g/15 ml solution United States - English - NLM (National Library of Medicine)

lactulose solution- lactulose solution usp, 10 g/15 ml solution

rising pharmaceuticals, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia level by 25 to 50%; this is generally paralleled by an improvement in the patients’ mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients’ protein tolerance is also frequently observed with lactulose solution therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose solution has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE - lactulose solution United States - English - NLM (National Library of Medicine)

lactulose - lactulose solution

fresenius kabi austria gmbh - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE solution United States - English - NLM (National Library of Medicine)

lactulose solution

morton grove pharmaceuticals, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.  

LACTULOSE solution LACTULOSE solution United States - English - NLM (National Library of Medicine)

lactulose solution lactulose solution

pharmaceutical associates, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

Lactulose Crescent 3.35 g/5 ml Solution Malta - English - Medicines Authority

lactulose crescent 3.35 g/5 ml solution

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - lactulose - oral solution - lactulose 3.35 g/5ml - drugs for constipation

Lactulose 3.335 g/5 ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

lactulose 3.335 g/5 ml oral solution

bristol laboratories limited - lactulose - oral solution - 3.335 g/5ml - osmotically acting laxatives; lactulose

Lactulose 10 g/15 ml Oral Solution Sachets Ireland - English - HPRA (Health Products Regulatory Authority)

lactulose 10 g/15 ml oral solution sachets

fresenius kabi austria gmbh - lactulose - oral solution - 10 g/15 millilitre(s) - osmotically acting laxatives; lactulose

Lactulose Fresenius 670mg/ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

lactulose fresenius 670mg/ml oral solution

fresenius kabi austria gmbh - lactulose - oral solution - 670 milligram(s)/millilitre - osmotically acting laxatives; lactulose